The consensus molecular subtypes (CMS) classification is one of the most robust colorectal
cancer (CRC) classifications based on comprehensive gene expression profiles. This study …

Background The consensus molecular subtypes (CMS) is a transcriptome-based
classification of colorectal cancer (CRC) initially described in early-stage cohorts, but the …

PURPOSE To determine the predictive and prognostic value of the consensus molecular
subtypes (CMSs) of colorectal cancer (CRC) that represent a merging of gene expression …

Background The consensus molecular subtypes (CMSs) of colorectal cancer (CRC) capture
tumor heterogeneity at the gene-expression level. Currently, a restricted number of …

3511 Background: CALGB 80405 was a randomized Ph3 trial showing no OS or PFS
difference in mCRC pts treated with Bevacizumab (BV) or Cetuximab (Cet) in the first line. A …

The identification of several genetic mutations in colorectal cancer (CRC) has allowed a
better comprehension of the prognosis and response to different antineoplastic treatments …

The classification of colorectal cancer (CRC) plays a pivotal role in predicting a patient's
prognosis and determining treatment strategies. The consensus molecular subtype (CMS) …

Gene expression-based subtypes of colorectal cancer have clinical relevance, but the
representativeness of primary tumors and the consensus molecular subtypes (CMS) for …

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
Similar to many other malignancies, CRC is a heterogeneous disease, making it a clinical …

Background Currently, metastatic colorectal cancer is treated as a homogeneous disease
and only RAS mutational status has been approved as a negative predictive factor in …